- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07597434
Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease
Understanding of the Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease Among Adolescents and Young Adults: An Exploratory Study
The study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:
- To investigate the understanding of non-communicable diseases among adolescents and young adults;
- To identify the prevalence of health-risk behaviours among adolescents and young adults;
- To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults
Studienübersicht
Status
Detaillierte Beschreibung
Chronic diseases, also known as non-communicable diseases (NCDs), are the leading causes of global morbidity and mortality, accounting for around 74% of all deaths worldwide. Cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes contribute to over 80% of premature NCD-related deaths. The World Health Organization identifies four key modifiable behavioural risk factors-tobacco use, harmful alcohol consumption, unhealthy diets, and physical inactivity-as major contributors to NCDs. Evidence shows that most premature deaths from NCDs are preventable through targeted interventions and sustainable lifestyle changes. In Hong Kong, the burden of NCDs is growing, driven by an aging population. The Hospital Authority projects a 50% increase in NCD cases among the middle-aged, rising from 2 million in 2019 to 3 million by 2039, posing a serious challenge to the healthcare system. In response, the government has pledged to strengthen district-based primary healthcare services, including establishing health centres across all districts and launching the Chronic Disease Co-Care Pilot Scheme in 2023 for adults aged 45 and above.
However, adolescence represents a critical developmental window characterized by rapid biological, cognitive, and emotional changes, as well as heightened exposure to social stressors. This stage is particularly vulnerable to the adoption of risk behaviours that often persist into adulthood and contribute to chronic health conditions. Notably, 97.4% of smokers in Hong Kong began smoking before age 30, underscoring the importance of early intervention. These findings highlight the need to initiate education and screening efforts at a younger age. The adage "an ounce of prevention is worth a pound of cure" is especially pertinent in public health. Reflecting this, the Hong Kong Government is transitioning its healthcare model from treatment-focused to prevention-oriented. Prioritizing early intervention during youth is essential for promoting lifelong health and well-being and represents one of the most effective strategies for reducing the prevalence of NCDs in Hong Kong.
Aim of Study
The aim of the study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:
- To investigate the understanding of non-communicable diseases among adolescents and young adults;
- To identify the prevalence of health-risk behaviours among adolescents and young adults;
- To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults
Outcome measures Primary outcomes: Information on four major health-risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs)
In what way will the research contribute to knowledge or healthcare development? The findings of this study will contribute to the development of appropriate interventions that targeting adolescents and young adults with health-risk behaviours with the aim to help them quit health-risk behaviours and adopt a healthy lifestyle.
Study subjects Inclusion criteria
- Aged 18 to 45 years
- Able to speak Cantonese
Exclusion criteria
- Studying medical, nursing and healthcare-related courses or working in medical, nursing, and allied health fields
- Those who had been diagnosed with NCDs
How will subjects be identified and recruited: To enhance the representativeness of the sample, we aim to recruit participants from all the 18 districts in the community.
Measures: A modified behavioural health-risk factor survey was used to collect demographic data and information regarding health-risk behaviours. The survey was a checklist adopted from the Hong Kong Department of Health (www.chp.gov.hk/files/pdf/brfs_2015apr_en.pdf, accessed on 5 January 2021).
Methods of Data Analysis Data will be entered into SPSS for Windows (version 28). A logic check program will be installed for entry validation. Descriptive statistics such as frequency, percentage, and mean will be used to summarize the outcomes and other variables. Chi-square tests and t-tests will be used to compare outcome variables between subgroups. The Pearson product moment correlation coefficient will be used to investigate the interrelationships.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Ho Cheung William Li, PhD
- Telefonnummer: +85239430889
- E-Mail: williamli@cuhk.edu.hk
Studienorte
-
-
-
Hong Kong, Hongkong
- Rekrutierung
- The Nethersole School of Nursing, The Chinese University of Hong Kong
-
Kontakt:
- Ho Cheung William Li, PhD
- Telefonnummer: +85239430889
- E-Mail: williamli@cuhk.edu.hk
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- (1) Aged 18 to 45 years
- (2) Able to speak Cantonese
Exclusion Criteria:
- (1) Studying medical, nursing and healthcare related courses or working in medical, nursing, and allied health fields
- (2) Those who had been diagnosed with non-communicable diseases
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Information on four major health risk behaviours
Zeitfenster: Baseline
|
Information on four major health risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs), will be collected by using a modify behavioural health-risk factor survey.
Data on tobacco use, alcohol consumption, fruit and vegetable intake, physical activity levels, and relevant lifestyle practices will be analysed to determine whether participants meet the World Health Organization (WHO) targets for the prevention and control of non-communicable diseases.
|
Baseline
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 0962
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Nicht übertragbare Krankheiten
-
Stanford UniversityNational Institutes of Health (NIH); AmgenAbgeschlossenLymphom, Non-Hodgkin | Lymphome: Non-Hodgkin | Lymphome: Periphere Non-Hodgkin-T-Zelle | Lymphome: Kutanes Non-Hodgkin-Lymphom | Lymphome: Non-Hodgkin Diffuse Large B-Zell | Lymphome: Non-Hodgkin Follikel / indolente B-Zelle | Lymphome: Non-Hodgkin-Mantelzelle | Lymphome: Non-Hodgkin-Randzone | Lymphome...Vereinigte Staaten
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.RekrutierungLymphom | Lymphom, Non-Hodgkin | Non-Hodgkin-Lymphom | Non-Hodgkin-Lymphom | Refraktäres B-Zell-Non-Hodgkin-Lymphom | Refraktäres Non-Hodgkin-Lymphom | Hochgradiges B-Zell-Lymphom | ZNS-Lymphom | Lymphome Non-Hodgkin-B-Zelle | Rezidiviertes Non-Hodgkin-Lymphom | Lymphom, Non-Hodgkins | Großes B-Zell-Lymphom | Lymphom, Non-Hodgkin, Erwachsener und andere BedingungenVereinigte Staaten
-
Mayo ClinicRekrutierungIndolentes B-Zell-Non-Hodgkin-Lymphom | Rezidivierendes indolentes Non-Hodgkin-Lymphom | Refraktäres indolentes Non-Hodgkin-Lymphom | Rezidivierendes indolentes B-Zell-Non-Hodgkin-Lymphom | Refraktäres indolentes B-Zell-Non-Hodgkin-LymphomVereinigte Staaten
-
University Hospital TuebingenAbgeschlossen
-
National Cancer Institute (NCI)Aktiv, nicht rekrutierendRefraktäres B-Zell-Non-Hodgkin-Lymphom | Refraktäres T-Zell-Non-Hodgkin-Lymphom | Rezidivierendes B-Zell-Non-Hodgkin-Lymphom | Wiederkehrendes transformiertes Non-Hodgkin-Lymphom | Rezidivierendes Non-Hodgkin-Lymphom | Refraktäres Non-Hodgkin-Lymphom | Wiederkehrendes T-Zell-Non-Hodgkin-Lymphom und andere BedingungenVereinigte Staaten
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutierungRefraktäres B-Zell-Non-Hodgkin-Lymphom | Rezidivierendes B-Zell-Non-Hodgkin-Lymphom | Hochgradiges B-Zell-Non-Hodgkin-Lymphom | B-Zell-Non-Hodgkin-Lymphom mittleren GradesVereinigte Staaten
-
Joseph TuscanoSpectrum Pharmaceuticals, IncAktiv, nicht rekrutierendRezidiviertes Non-Hodgkin-Lymphom | Refraktäres Non-Hodgkin-LymphomVereinigte Staaten
-
GC Cell CorporationUnbekanntRefraktäres Non-Hodgkin-Lymphom | Rezidiviertes Non-Hodgkin-LymphomKorea, Republik von
-
Loyola UniversityAbgeschlossenRefraktäres Non-Hodgkin-Lymphom | Rezidiviertes Non-Hodgkin-LymphomVereinigte Staaten
-
Chinese PLA General HospitalShenzhen University General Hospital; Shenzhen UniversityUnbekanntRefraktäres Non-Hodgkin-Lymphom | Rezidiviertes Non-Hodgkin-LymphomChina